BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32882024)

  • 1. Genome-Wide Association Study of Susceptibility Loci for TCF3-PBX1 Acute Lymphoblastic Leukemia in Children.
    Lee SHR; Qian M; Yang W; Diedrich JD; Raetz E; Yang W; Dong Q; Devidas M; Pei D; Yeoh A; Cheng C; Pui CH; Evans WE; Mullighan CG; Hunger SP; Savic D; Relling MV; Loh ML; Yang JJ
    J Natl Cancer Inst; 2021 Jul; 113(7):933-937. PubMed ID: 32882024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical outcomes and genomic landscapes of acute lymphoblastic leukemia patients with E2A-PBX1: A 10-year retrospective study.
    Zhou B; Chu X; Tian H; Liu T; Liu H; Gao W; Chen S; Hu S; Wu D; Xu Y
    Am J Hematol; 2021 Nov; 96(11):1461-1471. PubMed ID: 34406703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic features of B-cell lymphoblastic lymphoma with TCF3-PBX1.
    Shirai R; Osumi T; Sato-Otsubo A; Nakabayashi K; Mori T; Yoshida M; Yoshida K; Kohri M; Ishihara T; Yasue S; Imamura T; Endo M; Miyamoto S; Ohki K; Sanada M; Kiyokawa N; Ogawa S; Yoshioka T; Hata K; Takagi M; Kato M
    Cancer Rep (Hoboken); 2022 Sep; 5(9):e1559. PubMed ID: 34553842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple heterogeneous bone invasions of B lymphoblastic lymphoma with the TCF3/PBX1 fusion gene: a case report.
    Okura E; Saito S; Natsume T; Morita D; Tanaka M; Kiyokawa N; Nakazawa Y
    Int J Hematol; 2020 Feb; 111(2):163-165. PubMed ID: 31828595
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterisation of genomic translocation breakpoints and identification of an alternative TCF3/PBX1 fusion transcript in t(1;19)(q23;p13)-positive acute lymphoblastic leukaemias.
    Paulsson K; Jonson T; Ora I; Olofsson T; Panagopoulos I; Johansson B
    Br J Haematol; 2007 Jul; 138(2):196-201. PubMed ID: 17593026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare
    Miyamoto S; Urayama KY; Arakawa Y; Koh K; Yuza Y; Hasegawa D; Taneyama Y; Noguchi Y; Yanagimachi M; Inukai T; Ota S; Takahashi H; Keino D; Toyama D; Takita J; Tomizawa D; Morio T; Koike K; Moriwaki K; Sato Y; Fujimura J; Morita D; Sekinaka Y; Nakamura K; Sakashita K; Goto H; Manabe A; Takagi M
    Pediatr Hematol Oncol; 2024; 41(1):81-87. PubMed ID: 37129918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of TCF3 rearrangements in pediatric B-lymphoblastic leukemia/lymphoma by mate-pair sequencing (MPseq) identifies complex genomic rearrangements and a novel TCF3/TEF gene fusion.
    Rowsey RA; Smoley SA; Williamson CM; Vasmatzis G; Smadbeck JB; Ning Y; Greipp PT; Hoppman NL; Baughn LB; Ketterling RP; Peterson JF
    Blood Cancer J; 2019 Oct; 9(10):81. PubMed ID: 31575852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and prognostic significance of TCF3-PBX1 fusion gene in Chinese children with acute lymphoblastic leukemia by using a modified ALL-BFM-95 protocol.
    Pang L; Liang Y; Pan J; Wang JR; Chai YH; Zhao WL
    Pediatr Hematol Oncol; 2015 Apr; 32(3):173-81. PubMed ID: 25551271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of t(1;19)/ TCF3-PBX1 in childhood acute lymphoblastic leukemia in the context of Berlin-Frankfurt-Münster-based protocols.
    Felice MS; Gallego MS; Alonso CN; Alfaro EM; Guitter MR; Bernasconi AR; Rubio PL; Zubizarreta PA; Rossi JG
    Leuk Lymphoma; 2011 Jul; 52(7):1215-21. PubMed ID: 21534874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptic TCF3 fusions in childhood leukemia: Detection by RNA sequencing.
    Salim M; Heldt F; Thomay K; Lentes J; Behrens YL; Kaune B; Möricke A; Cario G; Schieck M; Hofmann W; Davenport C; Steinemann D; Schrappe M; Schlegelberger B; Göhring G
    Genes Chromosomes Cancer; 2022 Jan; 61(1):22-26. PubMed ID: 34460133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and prognostic impact of TCF3-PBX1 in childhood acute lymphoblastic leukemia: A single-center retrospective study of 837 patients from China.
    Jia M; Hu BF; Xu XJ; Zhang JY; Li SS; Tang YM
    Curr Probl Cancer; 2021 Dec; 45(6):100758. PubMed ID: 34034913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel susceptibility variants at the
    Qian M; Xu H; Perez-Andreu V; Roberts KG; Zhang H; Yang W; Zhang S; Zhao X; Smith C; Devidas M; Gastier-Foster JM; Raetz E; Larsen E; Burchard EG; Winick N; Bowman WP; Martin PL; Borowitz M; Wood B; Antillon-Klussmann F; Pui CH; Mullighan CG; Evans WE; Hunger SP; Relling MV; Loh ML; Yang JJ
    Blood; 2019 Feb; 133(7):724-729. PubMed ID: 30510082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.
    Karvonen H; Perttilä R; Niininen W; Hautanen V; Barker H; Murumägi A; Heckman CA; Ungureanu D
    Oncogene; 2019 Apr; 38(17):3288-3300. PubMed ID: 30631148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TCF3 gene rearrangements in pediatric B-cell acute lymphoblastic leukemia-A single center experience.
    Zerkalenkova E; Menchits Y; Borkovskaia A; Sokolova S; Soldatkina O; Mikhailova E; Popov A; Komkov A; Rumiantseva Y; Karachunskii A; Olshanskaya Y
    Int J Lab Hematol; 2023 Aug; 45(4):533-540. PubMed ID: 37058324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemia.
    Gabriel AS; Lafta FM; Schwalbe EC; Nakjang S; Cockell SJ; Iliasova A; Enshaei A; Schwab C; Rand V; Clifford SC; Kinsey SE; Mitchell CD; Vora A; Harrison CJ; Moorman AV; Strathdee G
    Epigenetics; 2015; 10(8):717-26. PubMed ID: 26237075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Results of the Risk-Stratified Treatment of TCF3-PBX1-Positive Pediatric Acute Lymphoblastic Leukemia in China.
    Wang Y; Xue YJ; Lu AD; Jia YP; Zuo YX; Zhang LP
    Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):e137-e144. PubMed ID: 33221150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia.
    Burmeister T; Gökbuget N; Schwartz S; Fischer L; Hubert D; Sindram A; Hoelzer D; Thiel E
    Haematologica; 2010 Feb; 95(2):241-6. PubMed ID: 19713226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A clinical and laboratory study of TCF3-PBX1 positive adult acute lymphoblastic leukemia.].
    Zheng JF; Qiu HY; Pan JL; Cen JN; Wu YF; Zhang J; Wu DP; Xue YQ
    Zhonghua Xue Ye Xue Za Zhi; 2010 Jan; 31(1):16-20. PubMed ID: 20302770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian children.
    Kager L; Lion T; Attarbaschi A; Koenig M; Strehl S; Haas OA; Dworzak MN; Schrappe M; Gadner H; Mann G;
    Haematologica; 2007 Nov; 92(11):1561-4. PubMed ID: 18024406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended vincristine and dexamethasone pulse therapy may not be necessary for children with TCF3-PBX1 positive acute lymphoblastic leukaemia.
    Wan Y; Zhang H; Zhang L; Cai J; Yu J; Hu S; Fang Y; Gao J; Jiang H; Yang M; Liang C; Jin R; Tian X; Ju X; Hu Q; Jiang H; Li H; Wang N; Sun L; Leung AWK; Wu X; Wang J; Li CK; Yang J; Tang J; Shen S; Zhai X; Pui CH; Zhu X
    Br J Haematol; 2022 Nov; 199(4):587-596. PubMed ID: 36114009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.